Isis Pharmaceuticals Inc
update 05/21
20.81
0.35 (1.71%%)
TODAY
High 20.85
Low 20.28
Open 20.45
Volume 906524
Time 05/21
52 WEEK SUMMARY
High 23.03
Low 7.55
P/E 0.00
Return
119.05%
Mkt Cap
2.324 B
Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis'broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=797443844&utmp=%2Fquote%2FISIS%3AUS&utmhn=10.248.179.13&utmac=UA-11413116-12&utmhid=605946251)